Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazoles
Biomolecules · 21.01.2023 · 13 (2) · 211
DOI: 10.3390/biom13020211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.01.2023. Verfasst von Vien Q T Ho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Control, Amsterdam UMC, Vrije Universiteit Medical Center, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Mycobacterium marinum, Mycobacterium tuberculosis, Type VII Secretion Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, Netherlands Organization for Scientific Research (NWO).
Abstract (Originalsprache)
The ESX-5 secretion system is essential for the viability and virulence of slow-growing pathogenic mycobacterial species. In this study, we identified a 1,2,4-oxadiazole derivative as a putative effector of the ESX-5 secretion system. We confirmed that this 1,2,4-oxadiazole and several newly synthesized derivatives inhibited the ESX-5-dependent secretion of active lipase LipY by Mycobacterium marinum (M. marinum). Despite reduced lipase activity, we did not observe a defect in LipY secretion itself. Moreover, we found that several other ESX-5 substrates, especially the high molecular-weight PE_PGRS MMAR_5294, were even more abundantly secreted by M. marinum treated with several 1,2,4-oxadiazoles. Analysis of M. marinum grown in the presence of different oxadiazole derivatives revealed that the secretion of LipY and the induction of PE_PGRS secretion were, in fact, two independent phenotypes, as we were able to identify structural features in the compounds that specifically induced only one of these phenotypes. Whereas the three most potent 1,2,4-oxadiazoles displayed only a mild effect on the growth of M. marinum or M. tuberculosis in culture, these compounds significantly reduced bacterial burden in M. marinum-infected zebrafish models. In conclusion, we report a 1,2,4-oxadiazole scaffold that dysregulates ESX-5 protein secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infection Control, Amsterdam UMC, Vrije Universiteit Medical Center, 1081 HV Amsterdam, The Netherlands.
- Department of Chemistry and Pharmaceutical Sciences, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
- Department of Medical Oncology, OncoProteomics Laboratory, AmsterdamUMC, Vrije Universiteit Medical Center, 1081 HV Amsterdam, The Netherlands.
- Department of Molecular Microbiology, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
ORCID-Profile: Eva Habjan, Eelco Ruijter
Förderung
- Dutch Research Council
- Netherlands Organization for Scientific Research (NWO)
Zitieren
APA
Ho, V. Q. T., Rong, M. K., Habjan, E., Bommer, S. D., Pham, T. V., Piersma, S. R., Bitter, W., Ruijter, E., & Speer, A. (2023). Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazoles. Biomolecules, 13(2), 211. https://doi.org/10.3390/biom13020211
Vancouver
Ho VQT, Rong MK, Habjan E, Bommer SD, Pham TV, Piersma SR, et al. Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazoles. Biomolecules. 2023;13(2):211. doi:10.3390/biom13020211
BibTeX
@article{Ho2023,
author = {Ho, Vien Q T and Rong, Mark K and Habjan, Eva and Bommer, Samantha D and Pham, Thang V and Piersma, Sander R and Bitter, Wilbert and Ruijter, Eelco and Speer, Alexander},
title = {Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazoles},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {2},
pages = {211},
doi = {10.3390/biom13020211}
}
EUVIMED